Cargando…

Investigation of time profile of FEV(1) across the onset of potential COPD: a retrospective cohort study using medical checkup data in Japan

This study compared the time profile of FEV(1) after COPD diagnosis among rapid decliners, slow decliners, and sustainers in the year of COPD diagnosis. COPD subjects were identified from the annual medical checkup records of Hitachi, Ltd., employees in Japan (April 1998-March 2019). Subjects were c...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Masaru, Matsumoto, Isao, Ishida, Masato, Horie, Yoshiharu, Ban, Hideyuki, Takeuchi, Wataru, Nakagawa, Shunki, Nakagawa, Tohru, Kitamura, Tetsuhisa, Muro, Shigeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070435/
https://www.ncbi.nlm.nih.gov/pubmed/37012340
http://dx.doi.org/10.1038/s41598-023-32205-3
Descripción
Sumario:This study compared the time profile of FEV(1) after COPD diagnosis among rapid decliners, slow decliners, and sustainers in the year of COPD diagnosis. COPD subjects were identified from the annual medical checkup records of Hitachi, Ltd., employees in Japan (April 1998-March 2019). Subjects were categorized into 3 groups (rapid decliner [decrease of FEV(1) ≥ 63 mL/year], slow decliner [< 63 and ≥ 31 mL/year], and sustainer [< 31 mL/year]) for 5 years. The time profile of FEV(1) was compared using mixed-effects model for 5 years after diagnosis; risk factors of rapid decliner were detected using logistic model/gradient boosting decision tree. Of 1294 eligible subjects, 18.6%, 25.7%, and 55.7% were classified as rapid decliners, slow decliners, and sustainers, respectively. The annual rates of FEV(1) decline were similar 3 years before and until COPD diagnosis. The mean FEV(1) in rapid decliners was 2.82 ± 0.04 L in year 0 and 2.41 ± 0.05 L in year 5, and in sustainers, it was 2.67 ± 0.02 L and 2.72 ± 0.02 L (year 0, p = 0.0004). In conclusion, FEV(1) declined yearly before diagnosis and the time profiles of FEV(1) were different in the 3 groups after COPD diagnosis. Therefore, appropriate treatment of the 3 groups with regular lung function tests is necessary to follow FEV(1) decline after COPD onset.